Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart risk study at major conference could shape future screening

NCT ID NCT07613229

Knowledge-focused Sponsor: European Society of Cardiology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study offered free heart health checks to 1366 healthcare professionals attending the ESC Congress 2025. Participants filled out questionnaires, had blood drawn, and received blood pressure and heart sound checks. The goal was to assess cardiovascular risk and inform future public health screening plans in Europe.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could support the development of European cardiovascular health screening programs for the general public.
What could go wrong
This is an observational study, not a treatment trial. It only measures risk factors in a specific group (healthcare professionals at a conference), so results may not apply to the broader population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,366 people

The number who actually took part.

Started

Aug 2025

Finished

Sep 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All adult attendees (including healthcare professional) attending the ESC Congress 2026 from August 29th to September 1st

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2025 from August 29th to September 1st * Subjects who declare that they are able to understand and give IC in English Exclusion Criteria: * Subjects not willing to provide his/her consent to participate in the study. * Subjects who are not suitable candidates for blood extraction.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular risk are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular risk

Contacts and locations

Locations

  • Evidenze Health España S.L.U.

    Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.